Incidence of noncommunicable diseases (NCDs) are increasing in Africa and according to the World Health Organization, NCDs are set to become the leading causes of mortality in sub-Saharan Africa by 2030.
Why molecular epidemiology research in Africa?
There is a dearth of knowledge on molecular determinants of disease, including non-communicable diseases in the African population. Molecular epidemiology incorporates molecular and laboratory technologies in traditional epidemiology studies aimed at understanding factors that can lead to disease. Our research is aimed at understanding the molecular mechanisms of NCDs in Africa to provide new insights to prevent, detect, diagnose and treat disease in Africa.
- To form a community of multidisciplinary investigators that exchanges knowledge, builds capacity for molecular epidemiology, data science and translational/clinical research in Africa
- To build capacity and increase the number of molecular epidemiology NCD research studies to further our understanding of the molecular pathogenesis of NCDs in Africa and burden for different types of NCDs
- Inform NCD control and treatment programs, engage key stakeholders (e.g. physicians, ministry of health, policy makers), to prioritize the key areas needed for long term planning to enhance capacity to tackle the increasing burden.